New Labcorp test report helps identify insect stings and improve therapy decisions to combat allergic reactions

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 19, 2022-- Nearly 10 million people in the United States have a history of systemic or anaphylactic reaction to insect stings, with the risk of a severe and potentially life-threatening allergic reaction.

Labcorp expands automated clinical trial kit production line at European operations center

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 18, 2022-- Labcorp ® (NYSE: LH), a leading global life sciences company, today announced an expansion of its automated clinical trial kit production line in Mechelen, Belgium.

Labcorp to announce second quarter financial results on July 28, 2022

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 14, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the second quarter of 2022 before the market opens on Thursday, July 28, 2022 . The company will host a conference call and webcast beginning at 9 a.m. EDT that day to discuss the results.

Labcorp declares quarterly dividend

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 14, 2022-- Labcorp (NYSE: LH) (the Company), a leading global life sciences company, announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 9, 2022 ,

Labcorp launches new test to identify and confirm neurodegenerative disease

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 13, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the launch of the first widely accessible test that provides direct evidence of neurodegeneration and neuronal injury.

Redi.Health collaborates with Labcorp to seamlessly connect patients and providers

COLUMBUS, O.H., July 12, 2022 — Today, Redi.Health, provider of health management technology that improves total patient health, is announcing a collaboration with Labcorp, a leading global life sciences company. Through this combined effort, Labcorp Drug Development’s Patient Access Solutions will integrate Redi.Health’s digital support platform to offer patients and their care providers a variety of digital and traditional communications channels and tools with real-time data synching to help patients better manage their health.